Source: Frontiers in Pharmacology. Unidade: FOB
Subjects: RECEPTORES DE ANGIOTENSINA, RATOS, DOENÇAS PERIODONTAIS, HIPERTENSÃO, MICROTOMOGRAFIA, OSTEOCLASTO, OSSO E OSSOS
ABNT
BRITO, Victor Gustavo Balera et al. Telmisartan prevents alveolar bone loss by decreasing the expression of osteoclasts markers in hypertensive rats with periodontal disease. Frontiers in Pharmacology, v. 11, 2020Tradução . . Disponível em: https://doi.org/10.3389/fphar.2020.579926. Acesso em: 28 abr. 2024.APA
Brito, V. G. B., Patrocinio, M. S., Sousa, M. C. L. de, Barreto, A. E. A., Frasnelli, S. C. T., Lara, V. S., et al. (2020). Telmisartan prevents alveolar bone loss by decreasing the expression of osteoclasts markers in hypertensive rats with periodontal disease. Frontiers in Pharmacology, 11. doi:10.3389/fphar.2020.579926NLM
Brito VGB, Patrocinio MS, Sousa MCL de, Barreto AEA, Frasnelli SCT, Lara VS, Santos CF dos, Oliveira SHP. Telmisartan prevents alveolar bone loss by decreasing the expression of osteoclasts markers in hypertensive rats with periodontal disease [Internet]. Frontiers in Pharmacology. 2020 ; 11[citado 2024 abr. 28 ] Available from: https://doi.org/10.3389/fphar.2020.579926Vancouver
Brito VGB, Patrocinio MS, Sousa MCL de, Barreto AEA, Frasnelli SCT, Lara VS, Santos CF dos, Oliveira SHP. Telmisartan prevents alveolar bone loss by decreasing the expression of osteoclasts markers in hypertensive rats with periodontal disease [Internet]. Frontiers in Pharmacology. 2020 ; 11[citado 2024 abr. 28 ] Available from: https://doi.org/10.3389/fphar.2020.579926